You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Occupational lung disease: the need for a global surveillance system
  1. Kaveh Asanati1,2,
  2. Shiboun Hamed Al Jassasi3,
  3. Alireza Sherafat4,
  4. Mark Ferris5
  1. 1 Department of Pharmacology Therapeutics and Toxicology, School of Medicine, Cardiff University, Cardiff, UK
  2. 2 National Heart and Lung Institute, London, UK
  3. 3 Occupational Health, Petroleum Development Oman, Ibri, Oman
  4. 4 School of Medicine, University of Central Lancashire, Preston, Lancashire, UK
  5. 5 Occupational Health, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
  1. Correspondence to Dr Kaveh Asanati, School of Medicine, Cardiff University Department of Pharmacology Therapeutics and Toxicology, Cardiff CF10 3AT, UK; AsanatiK{at}cardiff.ac.uk

http://dx.doi.org/10.1136/oemed-2019-106323

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Dear Editor,

    We read with great interest the editorial by Reynolds and Blanc1 on “forging effective surveillance for work-related lung disease”. On its 30th anniversary, the authors cleverly looked at initial objectives of Surveillance of Work-related and Occupational Respiratory Disease (SWORD) programme and how these objectives have been met over the last three decades.

    There is one point that we would like to add to what Reynolds and Blanc1 wrote about SWORD. This is the potential to globalise the successful SWORD surveillance system for capturing international data with a view to improving the health and well-being of all workers globally. A good indication is the recent epidemic of artificial stone silicosis, an emerging occupational lung disease which such a global surveillance system may have …

    View Full Text

    Footnotes

    • Twitter @aljsassi, @SherafatAlireza

    • Contributors KA: responsible for conception and design, contribution to acquisition of data, analysis and interpretation of data, drafting the article and revising it. SHAJ: contributions to design, acquisition of data, analysis and interpretation of data, drafting the article and revising it. AS: contributions to design, analysis and interpretation of data, drafting the article and revising it. MF: contributions to design, analysis and interpretation of data, drafting the article and revising it.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.